‘Pharma Bro’ Martin Shkreli in Trouble Again for Forming New Drug Company
Since last February, Shkreli has been banned “for life from directly or indirectly participating in any manner in the pharmaceutical industry”
Diagnosis & Disease Information
Outcomes May Be Better for Warfarin Users Who Stop Aspirin Use
Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events
How the Pandemic Changed Pharmacies
As the pandemic unfolded, the health care industry was forced to lean on community pharmacies.
New Report Identifies Causes, Potential Solutions for Drug Shortages
The FDA has issued a report assembled by the inter-agency Drug Shortages Task Force to determine the root causes of drug shortages, and to offer recommendations based on the insights from stakeholders in the private and public sectors to help prevent future drug shortages.
Inappropriate Prescribing Leads to Poor Outcomes in Older Adults
Potentially inappropriate prescribing tied to ED visits, adverse drug events, functional decline.
Prices Will Soon Be Included in TV Drug Ads
Regulations will require companies to disclose prices of meds costing more than $35 for a month’s supply
Gender Differences Seen in Adverse Drug Reactions
Differences found in reaction symptoms and types of drugs tied to adverse reactions
Pharmacy Closures and Medication Adherence: What’s the Link?
Pharmacy closures appear to impact cardiovascular medication adherence among older patients, according to findings from a retrospective cohort study published in JAMA Network Open.
Medication Hoarding in Hospitals Prevalent During Shortages, Says Survey
Frequent medication shortages have led to various allocation and rationing methods by pharmacy practice managers and/or pharmacy leaders (PPMs), according to results of a survey published in JAMA Internal Medicine.
Aetna-CVS Merger Approved
The companies involved in these mergers say they will improve coordination of care for consumers, but critics say consumers could be left with far fewer choices and potentially higher costs.
